HAE:NYSE
Haemonetics Corp
$102.92
arrow_upward
+0.07%(+0.070) 1D
$102.92
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 4, 4:00:03 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HAE...
Open
$101.59
High
$103.56
Low
$101.51
Mkt. cap
4.68B
Avg. vol.
815.62K
Volume
425.09K
P/E ratio
50.20
52-wk high
$109.57
52-wk low
$47.32
EPS
$2.05
Beta
0.54
Shares outstanding
45.50M
No. of employees
3K
Open
$101.59
High
$103.56
Low
$101.51
Mkt. cap
4.68B
Avg. vol.
815.62K
Volume
425.09K
P/E ratio
50.20
52-wk high
$109.57
52-wk low
$47.32
EPS
$2.05
Beta
0.54
Shares outstanding
45.50M
No. of employees
3K
News stories
From web sources and news partners
https://www.dars.gov.et/
·
3 months ago
HAE Q1 2026 Earnings: EPS Beats Estimates by Slim Margin, Stock Rises 2.98% - High Growth Earnings
Profile
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
About Haemonetics Corp
CEOChristopher Simon
Employees3.01K
Founded1971
HeadquartersBoston, Massachusetts, United States
SectorMedical device
Websitehaemonetics.com